BioProbe Diagnostics, a spinout from the National University of Ireland Galway, develops innovative PCR tests for the detection of microbial pathogens associated with water contamination in environmental and industrial processes. Our strong team of scientists, innovators and business experts, develops and markets these PCR test kits worldwide. Using patented technologies, our goal is to transform the global marketplace with rapid, accurate, cost-effective, and user-friendly PCR test kits. Our first product, Bio Lp-1, a transformative Legionella test kit, received the prestigious EU Fast Track to Innovation Award in 2020. It will be launched in early 2022 in collaboration with renowned international partners.
Company Details
- Founded
- -
- Address
- Business Innovation Centre, Newcastle Road,ireland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://bioprobedx.com/
- Keywords
- Microbiology, Novel Nucleic Acid Diagnostics (NAD) Proprietary Technologies, Biotechnology.
- HQ
- Galway
Bioprobe Diagnostics Questions
Bioprobe Diagnostics's website is https://bioprobedx.com/
Bioprobe Diagnostics's LinkedIn profile is https://ie.linkedin.com/company/bioprobe-diagnostics
Bioprobe Diagnostics's industry is
Biotechnology Research
Bioprobe Diagnostics's top competitors are
Episeedlink,
Median Healthcare Services,
Glasport Bio,
Genicity,
Seamegro,
Bactivax Itn,
Unilever,
Endoval Ltd,
Kersia Healthcare,
Genaxxon Bioscience Gmbh.
Bioprobe Diagnostics's categories are Biotechnology Research
Bioprobe Diagnostics's founding year is 2017
